share_log

China Medical System Holdings (HKG:867) Has A Pretty Healthy Balance Sheet

China Medical System Holdings (HKG:867) Has A Pretty Healthy Balance Sheet

中国医疗控股公司(HKG: 867)的资产负债表相当不错
Simply Wall St ·  04/26 20:23

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know worries about.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses. We can see that China Medical System Holdings Limited (HKG:867) does use debt in its business. But the real question is whether this debt is making the company risky.

霍华德·马克斯说得好,他说的不是担心股价的波动,而是 “永久损失的可能性是我担心的风险... 也是我认识的每位实际投资者所担心的风险。”当你检查公司的资产负债表的风险时,考虑它的资产负债表是很自然的,因为企业倒闭时通常会涉及债务。我们可以看到,中国医疗控股有限公司(HKG: 867)确实在其业务中使用了债务。但真正的问题是这笔债务是否使公司面临风险。

When Is Debt Dangerous?

债务何时危险?

Debt is a tool to help businesses grow, but if a business is incapable of paying off its lenders, then it exists at their mercy. If things get really bad, the lenders can take control of the business. However, a more usual (but still expensive) situation is where a company must dilute shareholders at a cheap share price simply to get debt under control. Of course, plenty of companies use debt to fund growth, without any negative consequences. When we examine debt levels, we first consider both cash and debt levels, together.

债务是帮助企业增长的工具,但如果企业无法还清贷方,那么债务就任其摆布。如果情况变得非常糟糕,贷款人可以控制业务。但是,更常见(但仍然昂贵)的情况是,公司必须以低廉的股价稀释股东,这样才能控制债务。当然,许多公司使用债务为增长提供资金,而不会产生任何负面后果。当我们研究债务水平时,我们首先要同时考虑现金和债务水平。

What Is China Medical System Holdings's Net Debt?

中国医疗控股的净负债是多少?

You can click the graphic below for the historical numbers, but it shows that China Medical System Holdings had CN¥1.29b of debt in December 2023, down from CN¥1.78b, one year before. However, its balance sheet shows it holds CN¥6.14b in cash, so it actually has CN¥4.86b net cash.

你可以点击下图查看历史数字,但它显示中国医疗系统控股在2023年12月有12.9亿元人民币的债务,低于一年前的17.8亿元人民币。但是,其资产负债表显示其持有61.4亿元人民币的现金,因此实际上拥有48.6亿元人民币的净现金。

debt-equity-history-analysis
SEHK:867 Debt to Equity History April 27th 2024
SEHK: 867 2024 年 4 月 27 日债务与股本比率的历史记录

How Healthy Is China Medical System Holdings' Balance Sheet?

中医控股的资产负债表有多健康?

The latest balance sheet data shows that China Medical System Holdings had liabilities of CN¥2.05b due within a year, and liabilities of CN¥125.6m falling due after that. Offsetting these obligations, it had cash of CN¥6.14b as well as receivables valued at CN¥1.86b due within 12 months. So it can boast CN¥5.83b more liquid assets than total liabilities.

最新的资产负债表数据显示,中国医疗系统控股的负债为20.5亿元人民币,之后到期的负债为1.256亿元人民币。除这些债务外,它有61.4亿元人民币的现金以及价值18.6亿元人民币的应收账款将在12个月内到期。因此,它拥有的流动资产可以多出58.3亿元人民币 负债。

This luscious liquidity implies that China Medical System Holdings' balance sheet is sturdy like a giant sequoia tree. Having regard to this fact, we think its balance sheet is as strong as an ox. Simply put, the fact that China Medical System Holdings has more cash than debt is arguably a good indication that it can manage its debt safely.

这种丰厚的流动性意味着中医控股的资产负债表像一棵巨型红杉树一样坚固。考虑到这一事实,我们认为其资产负债表像牛一样强劲。简而言之,中国医疗控股的现金多于债务这一事实可以说是一个很好的迹象,表明它可以安全地管理债务。

In fact China Medical System Holdings's saving grace is its low debt levels, because its EBIT has tanked 24% in the last twelve months. When it comes to paying off debt, falling earnings are no more useful than sugary sodas are for your health. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately the future profitability of the business will decide if China Medical System Holdings can strengthen its balance sheet over time. So if you're focused on the future you can check out this free report showing analyst profit forecasts.

实际上,中国医疗控股的救命之处在于其低债务水平,因为其息税前利润在过去十二个月中下降了24%。在还清债务方面,收入下降对健康的作用并不比含糖的苏打水更有用。在分析债务水平时,资产负债表是显而易见的起点。但最终,该业务的未来盈利能力将决定中国医疗控股公司能否随着时间的推移加强其资产负债表。因此,如果您专注于未来,可以查看这份显示分析师利润预测的免费报告。

But our final consideration is also important, because a company cannot pay debt with paper profits; it needs cold hard cash. China Medical System Holdings may have net cash on the balance sheet, but it is still interesting to look at how well the business converts its earnings before interest and tax (EBIT) to free cash flow, because that will influence both its need for, and its capacity to manage debt. Over the last three years, China Medical System Holdings recorded free cash flow worth a fulsome 80% of its EBIT, which is stronger than we'd usually expect. That positions it well to pay down debt if desirable to do so.

但是我们最终的考虑因素也很重要,因为公司无法用纸面利润来偿还债务;它需要冷硬现金。China Medical System Holdings的资产负债表上可能有净现金,但研究该企业将其息税前收益(EBIT)转换为自由现金流的效果仍然很有趣,因为这将影响其对债务的需求和管理能力。在过去三年中,中国医疗系统控股录得的自由现金流相当于其息税前利润的80%,比我们通常预期的要强。如果需要的话,这有利于偿还债务。

Summing Up

总结

While we empathize with investors who find debt concerning, you should keep in mind that China Medical System Holdings has net cash of CN¥4.86b, as well as more liquid assets than liabilities. The cherry on top was that in converted 80% of that EBIT to free cash flow, bringing in CN¥2.2b. So we don't think China Medical System Holdings's use of debt is risky. The balance sheet is clearly the area to focus on when you are analysing debt. However, not all investment risk resides within the balance sheet - far from it. For example - China Medical System Holdings has 2 warning signs we think you should be aware of.

虽然我们同情那些认为债务令人担忧的投资者,但您应该记住,中国医疗系统控股的净现金为4.86亿元人民币,流动资产也比负债多。最重要的是,它将息税前利润的80%转换为自由现金流,带来了22亿元人民币的收入。因此,我们认为中国医疗控股公司使用债务没有风险。资产负债表显然是分析债务时需要关注的领域。但是,并非所有的投资风险都存在于资产负债表中,远非如此。例如,中国医疗控股有两个警告信号,我们认为您应该注意。

When all is said and done, sometimes its easier to focus on companies that don't even need debt. Readers can access a list of growth stocks with zero net debt 100% free, right now.

当一切都说完之后,有时更容易将注意力集中在甚至不需要债务的公司上。读者现在可以100%免费访问净负债为零的成长型股票清单。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发